One Step Closer to Implantable Heart Patches

Carcinotech bioprints patient-specific test models with cells from biopsy samples and has benefited greatly from CELLINK’s expertise in the field.

Rensselaer Polytechnic Institute has developed a bioink of human cells and animal collagen using CELLINK’s BIO X bioprinter.

University of Technology in Sydney is developing bioprinted heart tissue on demand with patient-specific cells to minimize the risk of transplant rejection.

Ronawk mass-produces adult stem cells using bioprinters from CELLINK paving the way for the possibility to grow and transplant patients’ own stem cells without the need for the immunosuppressive drugs that are usually required after an organ donation.